Publicaciones en colaboración con investigadores/as de Imperial College London (17)

2024

  1. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

    Matrix Biology, Vol. 132, pp. 1-9

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

  3. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

    Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694

2022

  1. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2012

  1. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis

    Clinical Cancer Research, Vol. 18, Núm. 4, pp. 969-980

  2. Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort

    European Respiratory Journal, Vol. 40, Núm. 1, pp. 177-184

2005

  1. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation

    FEBS Journal, Vol. 272, Núm. 1, pp. 97-108

2003

  1. Identification and characterization of a natural R96CEPCR variant

    Journal of Thrombosis and Haemostasis

2001

  1. Haemostatic genetic risk factors in arterial thrombosis

    Thrombosis and Haemostasis

1996

  1. Distribution of peptidyl-glycine α-amidating mono-oxygenase (PAM) enzymes in normal human lung and in lung epithelial tumors

    Journal of Histochemistry and Cytochemistry, Vol. 44, Núm. 1, pp. 3-12

1994

  1. Endothelin-like immunoreactivity in midgut endocrine cells of the desert locust, Locusta migratoria

    General and Comparative Endocrinology, Vol. 93, Núm. 1, pp. 9-20

1992

  1. A novel granular cell type of locust Malpighian tubules: ultrastructural and immunocytochemical study

    Cell & Tissue Research, Vol. 268, Núm. 1, pp. 123-130

  2. CGRP-immunoreactive endocrine cell proliferation in normal and hypoxic rat lung studied by immunocytochemical detection of incorporation of 5′-bromodeoxyuridine

    Cell & Tissue Research, Vol. 268, Núm. 1, pp. 9-15

  3. Simultaneous immunostaining method for localization of bromodeoxyuridine and calcitonin gene-related peptide

    Journal of Histochemistry and Cytochemistry, Vol. 40, Núm. 8, pp. 1121-1128